Bizarre Patents
Microwave Oven With Removable Storage Cassette in Dashboard of Motor Vehicle
A microwave oven adapted for use within a motor vehicle dashboard area. The microwave oven has a removable storage cassette, and slidable platforms for securing and serving containers of beverages and foods.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110039765 | Bioactive Molecules Produced by Probiotic Bacteria The present invention is a method for isolating bioactive molecules secreted by probiotic bacteria such as Lactobacillus rhamnosus, and methods for using such bioactive molecules to decrease replication of human immunodeficiency virus, expression of inflammatory ... | 02/17/2011 |
| 20110038899 | Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents Pharmaceutical solutions containing hydrophobic or lipophilic therapeutic agents and methods for producing the same are provided. Pharmaceutical solutions of the invention are produced by dissolving the therapeutic agent in one or more tocopherols or tocotrienols and on... | 02/17/2011 |
| 20110034528 | Elansolids, Novel Natural Metabolites of Flexibacter and Antibiotically Active Derivatives Thereof The present invention describes Elansolids, a new class of novel anti-bacterial compounds of formula (I). ... | 02/10/2011 |
| 20110028555 | Antiinflammatory and Analgesic Preparation for External Use It is intended to provide an antiinflammatory and analgesic preparation for external use whereby side effects of a nonsteroidal antiinflammatory and analgesic drug on the skin can be regulated, the nonsteroidal antiinflammatory and analgesic drug can be prevented from d... | 02/03/2011 |
| 20110015649 | Surgical Guidance Utilizing Tissue Feedback A surgical system is for use with a surgical tool and a tissue characteristic sensor associated with the surgical tool. The system has an expected tissue characteristic for tissue on a predefined trajectory of the tool in a patient, and a controller to receive a sensed ... | 01/20/2011 |
| 20110014697 | Method and Kit for Rapid Isolation of Human Foxp3+ Treg Cells The present invention relates to methods for isolating human forkhead box P3 (Foxp3+) CD4+ regulatory T cells (herein referred to as Foxp3+ Treg cells) from a sample containing (i) peripheral blood mononuclear cells (PBMCs), (ii) a lymphocyte containing fluid, or (iii) ... | 01/20/2011 |
| 20110014202 | Methods for Diagnosing and Treating Neuroendocrine Cancer The present invention relates to a method for diagnosing neuroendocrine cancers via detecting the presence of N-methyl D-asparate-associated (NMDA) glutamate receptors type 1 and/or type 2. Methods for preventing and treating neuroendocrine cancers are also disclosed.... | 01/20/2011 |
| 20110008438 | Bone Repair Composition and a Method of Making the Same Bone repair composition and method of making the same, the bone repair composition being formed by firstly mixing a first aqueous calcium phosphate suspension with bone graft granules to form an intermediate mixture. The intermediate mixture is then mixed with a second ... | 01/13/2011 |
| 20110008311 | Animal Model and Use of 17Beta-Hydroxysteroid Dehydrogenase Type 7 in the Diagnosis of Anencephaly The present invention features a non-human animal in which is deficient in the expression of endogenous 17β Hydroxysteroid Dehydrogenases Type 7 and use of the same in screening methods for agents that prevent or treat anencephaly. The present invention also provides a... | 01/13/2011 |
| 20110003349 | L-Threonine Overproducing Microorganism and Method for Preparing L-Threonine Using the Same The present invention relates to a mutant microorganism producing a high concentration of L-threonine in high yield, prepared using site-specific mutation, not random mutation, such as treatment with a mutation inducer, a method for preparing the same, and a method for ... | 01/06/2011 |
| 20100324019 | Use of Riboflavin in the Treatment of Hypertension The invention provides the use of riboflavin in the manufacture of a medicament for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism. The invention also provides a pharmaceutical product for... | 12/23/2010 |
| 20100317628 | MicroRNA Modulators and Method for Identifying and Using the Same The present invention is a method for identifying agents which modulate microRNA activity. The invention involves contacting a cell harboring a microRNA and a microRNA binding sequence, which is operably linked to a nucleic acid molecule encoding a reporter protein, wit... | 12/16/2010 |
| 20100311686 | Nutraceutical composition and methods for preventing or treating multiple sclerosis The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.... | 12/09/2010 |
| 20100310954 | Method for frost protection in a direct methanol fuel cell Systems and methods for protecting fuel cell systems from frost by introduction of a freezing point depressant into the fuel cell system and/or flushing the fuel cell system with an insert gas are provided.... | 12/09/2010 |
| 20100303833 | Method for Identifying a MHC Class H-Dependent Tumor Associated T Helper Cell Antigen The present invention is a method for identifying MHC class II-dependent disease-associated antigens. The instant method involves expressing a library of disease-derived proteins in lytic bacteriophage for subsequent presentation by antigen presenting cells to T helper ... | 12/02/2010 |
| 20100298281 | Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer The present invention relates to steroid-derived cyclopamine analogs and methods for using the same for inhibiting sonic hedgehog signaling and preventing or treating cancer. A method for synthesizing the analogs of the present invention from a steroid is also provided.... | 11/25/2010 |
| 20100297099 | Airway Administration of Activated Protein C in Inflammatory Conditions Affecting the Respiratory Tract The present invention provides methods for the local treatment of acute and chronic extravascular pulmonary fibrin deposition and/or reducing unwanted effects associated with systemic administration of anticoagulants to a subject via airway administration to the subject... | 11/25/2010 |
| 20100297017 | Method for Synthesizing and Using Pegylated Peptide-Photoactive Chromophore Conjugates and Micellular Formulations Thereof The invention relates to a PEGylated peptide-chromophore conjugate, which forms irregular micelles, for use in photodiagnostic and phototherapeutic applications. Methods for synthesizing and using the conjugates of the invention are also provided.... | 11/25/2010 |
| 20100286362 | Mammalian MDM2 Binding Proteins and Uses Thereof Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these protein... | 11/11/2010 |
| 20100285035 | High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 High affinity antibody antagonists of human interleukin-13 receptor alpha 1 are disclosed. The antibody molecules are effective in the inhibition of IL-13Rα1-mediated activities and, accordingly, present desirable antagonists for the use in the treatment of conditions ... | 11/11/2010 |
| 20100279926 | Compositions and Methods for Treating Atherosclerosis Peptides and mimetics of selected domains of mammalian serum amyloid A isoform 2.1 (SAA2.1) and compounds and compositions thereof are provided that enhance the effect on macrophage cholesterol ester hydrolase activity and/or inhibit acyl CoA:cholesterol acyl transferas... | 11/04/2010 |
| 20100279925 | Airway Administration of Site-Inactived FVIIA in Inflammatory Conditions Affecting the Respiratory Tract The present invention provides methods for the local treatment of acute and chronic extravascular pulmonary fibrin deposition and/or reducing unwanted effects associated with systemic administration of natural anticoagulants to a subject via airway administration to the... | 11/04/2010 |
| 20100272817 | Compositions and Methods for Treating Atherosclerosis Reverse peptides and mimetics of a mammalian serum amyloid A isoform 2.1 (SAA2.1) domain or a portion thereof and compositions and pharmaceutical compositions thereof are provided that enhance the effect on macrophage cholesterol ester hydrolase activity. Methods of usi... | 10/28/2010 |
| 20100267833 | Compositions and methods for preventing or treating an inflammatory response The present invention relates to methods for modulating the inflammatory response of respiratory tract cells using an agent that increases ceramide levels in the cells of the respiratory tract.... | 10/21/2010 |
| 20100267105 | Method for Micromanipulation of Cells The present invention is a method for manipulating living cells in vitro using poly-2-hydroxyethylmethacrylate-coated surfaces and optical tweezers to obtain cells in isolation or to create specific cell-cell interactions.... | 10/21/2010 |
| 20100260804 | Attenuated Uracil Auxotroph of an Apicomplexan and Use Thereof Uracil auxotroph mutants of apicomplexans are provided which lack a functional carbamoyl phosphate synthase II (CPSII) enzyme. Also provided are T. gondii autoxtroph mutants which express exogenous antigens, and methods of protecting an animal against a T. gon... | 10/14/2010 |
| 20100256063 | Method for Increasing Cardiac Mass and Performance The present invention relates to methods of using a proline/arginine-rich peptide such PR11 or PR39 for increasing cardiac mass or performance and in the treatment of heart failure.... | 10/07/2010 |
| 20100255082 | Functionally Coated Breakable Tablets Tablet and capsule formulations with a similar in vitro drug release profile for whole tablet and when broken and/or a bioequivalent drug release profile when taken whole or when broken are provided. In addition, coated splittable tablets are provided. Methods for produ... | 10/07/2010 |
| 20100248280 | Method for Identifying a Compound that Modulates Telomerase Activity The present invention relates to a method for identifying compounds that modulate the activity of telomerase. Compounds of the invention are identified by designing or screening for a compound which binds to at least one amino acid residue of the TRBD, “thumb,” “f... | 09/30/2010 |
| 20100248066 | Modified Fuel Cell Manifolds for Controlling Fuel Gas Flow to Different Sections of Fuel Cell Stacks A fuel delivery manifold enlarged in size is provided which, when incorporated into fuel cells which are then stacked allows for insertion of a baffle or a perforated fuel delivery tube through the fuel cell stack via the enlarged fuel delivery manifold to enhance and/o... | 09/30/2010 |
| 20100239597 | Anti-ADDL monoclonal antibody and use thereof The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts... | 09/23/2010 |
| 20100227932 | Patch A Bisoprolol patch, wherein the skin penetration rate of Bisoprolol after 24 hours is 15 to 60% of the maximum skin penetration rate thereof, shows a little difference between the maximum level of the concentration in blood and the minimum level thereof in repeated admi... | 09/09/2010 |
| 20100227816 | Use of GLP-1 Analogues for the Treatment of Disorders Associated with Dysfunctional Synaptic Transmission The present invention relates to a peptide analogue of glucagon-like peptide-1 (7-36), which is useful to prophylactically prevent, improve, or reverse the diminished cognitive function associated with these types of disorders, by increasing (or sustaining) the LTP of s... | 09/09/2010 |
| 20100227793 | Compositions and Methods for Treating Amyotrophic Lateral Sclerosis The invention relates to methods for preserving fast axonal transport in a cell affected by Amyotrophic Lateral Sclerosis by inhibiting pathogenic superoxide dismutase-induced increases in p38α activity. The present invention also provides methods for identifying agent... | 09/09/2010 |
| 20100216853 | Methods and Compositions for Modulating P300/CBP Activity The present invention relates to a method for identifying compounds that modulate the activity of p300/CBP. Compounds of the invention are identified by designing or screening for a compound which binds to at least one amino acid residue of the newly identified lysine-C... | 08/26/2010 |
| 20100216661 | Diagnostic Assay The present invention relates to mimotopes of blood group antigens, methods for identifying mimotopes of blood group antigens and methods for identifying antibodies to blood group antigens using said mimotopes.... | 08/26/2010 |
| 20100210824 | Method of Identifying Drugs, Targeting Moieties or Diagnostics The present invention relates to a method for identifying a binding agent or epitope for use in drug design, drug targeting or diagnostics. The method employs contacting and sorting binding agents and cognate epitopes from collections thereof, characterizing the binding... | 08/19/2010 |
| 20100210031 | Diagnostic Test to Exclude Significant Renal Injury Methods for determining the risk of developing acute renal failure in a human subject by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided. ... | 08/19/2010 |
| 20100210022 | Systems for and Methods of Detecting Mastitis Method and systems for determining if one or more animals has mastitis and for monitoring animals and the quality of the milk they produce are disclosed. Systems and test assays disclosed are used to determine the quantity of proteasomes and proteins thereof, the activi... | 08/19/2010 |
| 20100209438 | OVR110 Antibody Compositions and Methods of Use The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Ovr110) antibodies that internalize upon binding to Ovr110 on a mammalian in vivo. The invention also encompasses compositions comprising an anti-Ovr110 antibody and a carrier. Thes... | 08/19/2010 |
